SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-249158
Filing Date
2021-08-17
Accepted
2021-08-17 16:19:38
Documents
4
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 DEF 14A d191826ddef14a.htm DEF 14A 327209
2 GRAPHIC g191826g01a53.jpg GRAPHIC 42539
3 GRAPHIC g191826g02q42.jpg GRAPHIC 145142
4 GRAPHIC g191826g03e49.jpg GRAPHIC 118406
  Complete submission text file 0001193125-21-249158.txt   739242
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: DEF 14A | Act: 34 | File No.: 001-36830 | Film No.: 211183016
SIC: 2834 Pharmaceutical Preparations